EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cullin‐associated and neddylation‐dissociated 1 regulate reprogramming of lipid metabolism through SKP1‐Cullin‐1‐F‐box FBXO11 ‐mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma

Hao Zhang, Peng Xia, Zhangshuo Yang, Jie Liu, Yimin Zhu, Zan Huang, Zhonglin Zhang, Yufeng Yuan iD

Clinical and Translational Medicine · 2023

DOI: 10.1002/ctm2.1443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2023. Verfasst von Hao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, F-Box Proteins. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Enhanced de novo lipogenesis is essential for hepatocellular carcinoma (HCC). Abnormally high cullin‐associated and neddylation‐dissociated 1 (CAND1) expression is associated with poor clinical prognosis in HCC. The SKP1‐Cullin‐1‐F‐box (SCF) complex consists of the SKP1, Cullin‐1 and F‐box proteins (FBPs) and performs multiple functions including adipogenesis. SCF complex was modulated by CAND1, but Whether and how the CAND1 promotes HCC by regulating SCF complex and lipogenesis are unknown.

Methods

HCC samples were used to analyze the correlations between CAND1 expression and clinicopathological characteristics such as survival and prognosis. The in vitro functions of CAND1, FBXO11 and heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) were measured by cell proliferation, colony formation and migration assays. The in vivo functions were tested in multiple mouse liver cancer models including patient‐derived xenograft (PDX), cell line‐derived xenograft and AKT/NRASV12‐induced primary liver cancer models. Injections of adeno‐associated virus targeting CAND1 (AAV‐shCAND1) were performed to evaluate the therapeutic efficacy of targeting CAND1. RNA‐Seq and lipidomic assays followed by serial biochemical experiments including mass spectrometry, immunoprecipitation and GST pull‐down were performed to dissect the underlying mechanisms.

Results

CAND1 promoted the expression of lipid synthesis genes by disrupting SCF complex assembly and lipid accumulation. Furthermore, we identified hnRNPA2B1 as a novel F‐box protein 11 (FBXO11)‐binding partner. FBXO11 directly bound to hnRNPA2B1 and promoted hnRNPA2B1 ubiquitination and subsequent degradation. Our evaluations of the therapeutic efficacy of AAV‐shCAND1 injections confirmed that targeting the CAND1‐SCF FBXO11 ‐hnRNPA2B1A signalling axis was therapeutically effective. CAND1 downregulation significantly reduced the tumour burden in a primary mouse liver cancer model and a PDX model.

Conclusions

Our results highlight that CAND1 is associated with poor prognosis in HCC and regulates lipid metabolic reprogramming by dissociating the SCF complex. Targeting the CAND1‐SCF FBXO11 ‐hnRNPA2B1 axis may be a novel strategy for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsF-Box ProteinsAnimalsMiceHumansCullin ProteinsSKP Cullin F-Box Protein LigasesLipid MetabolismUbiquitinationHeterogeneous-Nuclear RibonucleoproteinsLipidsS-Phase Kinase-Associated ProteinsProtein-Arginine N-Methyltransferases

Stichwörter der Autor:innen

SCF complexadeno-associated virushepatocellular carcinomalipid metabolism reprogrammingubiquitination

Substanzen

Cullin ProteinsSKP Cullin F-Box Protein LigasesHeterogeneous-Nuclear RibonucleoproteinsLipidsSKP1 protein, humanS-Phase Kinase-Associated ProteinsFBXO11 protein, humanProtein-Arginine N-MethyltransferasesF-Box Proteins

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Clinical Medicine Research Center for Minimally Invasive Procedure of Hepatobiliary & Pancreatic Diseases of Hubei Province, Wuhan, China.
  • Department of Organ Transplantation, Qilu Hospital of Shandong University, Jinan, China.
  • Department of Breast Surgery, Affiliated Hospital of Hebei University, Baoding, China.
  • TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, China.
  • College of Life Sciences, Wuhan University, Wuhan, China.

ORCID-Profile: Yufeng Yuan

Zitieren

APA

Zhang, H., Xia, P., Yang, Z., Liu, J., Zhu, Y., Huang, Z., Zhang, Z., & Yuan, Y. (2023). Cullin‐associated and neddylation‐dissociated 1 regulate reprogramming of lipid metabolism through SKP1‐Cullin‐1‐F‐box FBXO11 ‐mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1443

Vancouver

Zhang H, Xia P, Yang Z, Liu J, Zhu Y, Huang Z, et al. Cullin‐associated and neddylation‐dissociated 1 regulate reprogramming of lipid metabolism through SKP1‐Cullin‐1‐F‐box FBXO11 ‐mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma. Clinical and Translational Medicine. 2023. doi:10.1002/ctm2.1443

BibTeX
@article{Zhang2023,
  author = {Zhang, Hao and Xia, Peng and Yang, Zhangshuo and Liu, Jie and Zhu, Yimin and Huang, Zan and Zhang, Zhonglin and Yuan, Yufeng},
  title = {Cullin‐associated and neddylation‐dissociated 1 regulate reprogramming of lipid metabolism through SKP1‐Cullin‐1‐F‐box FBXO11 ‐mediated heterogeneous nuclear ribonucleoprotein A2/B1 ubiquitination and promote hepatocellular carcinoma},
  journal = {Clinical and Translational Medicine},
  year = {2023},
  doi = {10.1002/ctm2.1443}
}
Kostenlos starten →